| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/24/2006 | US7125687 Presenilin enhancers assays |
| 10/24/2006 | US7125686 Proteins and methods for producing the proteins |
| 10/24/2006 | US7125684 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER) |
| 10/24/2006 | US7125679 Methods to screen peptide libraries using minicell display |
| 10/24/2006 | US7125676 Modified human sodium channel type 1 alpha subunit (SCN1A) nucleic acid that encodes an SCN1A voltage-gated sodium channel polypeptide that regulates Na+ ion membrane permeation; identifying a sodium channel modulator |
| 10/24/2006 | US7125675 Method for inhibiting tumor invasion or spreading in a subject |
| 10/24/2006 | US7125673 Preparing DNA from paraffin-embedded, formalin-fixed tissue samples for promoter methylation analysis by deparaffinizing the samples; boiling them in citrate buffer; and extracting DNA from them; hypermethylation of ATM gene promoter correlates with decreased overall head & neck cancer survival |
| 10/24/2006 | US7125672 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 10/24/2006 | US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides |
| 10/24/2006 | US7125666 A nucleic acid encodes the polypeptide or fragment has ability to form a triple helix, form higher order collagen fibrils or fibers and provide tensile strenght or flexibility to muscle connective tissue, recognized by R34 antibody |
| 10/24/2006 | US7125662 Identifying microorganismal nucleotide sequences associated with antibiotic resistance protein for use as components to improve identification of vector transformed cells |
| 10/24/2006 | US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein |
| 10/24/2006 | US7125556 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 10/24/2006 | US7125554 Engineered superantigen for human therapy |
| 10/24/2006 | US7125549 Synergistic combination of two adenoviral vectors that are replication incompetent cotranscomplements of each other and one is recombinant 1014; enhances both gene delivery and gene expression of genetic sequences contained within the vector. |
| 10/24/2006 | US7125548 Nucleotide sequences coding microorganismal cistron; for use in detection of microoganismal infection |
| 10/24/2006 | CA2342948C Attenuated vaccine for blastomyces dermatitidis |
| 10/24/2006 | CA2211165C Methods for sensitive detection of reverse transcriptase |
| 10/24/2006 | CA2121545C Method for transforming monocotyledons |
| 10/24/2006 | CA2104508C Improved method for nucleic acid amplification |
| 10/21/2006 | CA2541986A1 Carbonic anhydrase having increased stability under high temperatue conditions |
| 10/19/2006 | WO2006110915A2 Vaccine formulations for leishmania |
| 10/19/2006 | WO2006110852A1 System for producing synthetic promoters |
| 10/19/2006 | WO2006110813A2 Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases |
| 10/19/2006 | WO2006110689A2 Method of increasing the function of an aav vector |
| 10/19/2006 | WO2006110688A2 Rnai therapeutic for respiratory virus infection |
| 10/19/2006 | WO2006110680A1 Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome formation |
| 10/19/2006 | WO2006110677A2 Gene inactivated mutants with altered protein production |
| 10/19/2006 | WO2006110607A2 Methods for treating infectious disease exacerbated asthma |
| 10/19/2006 | WO2006110594A2 Sema4d in cancer diagnosis, detection and treatment |
| 10/19/2006 | WO2006110508A2 Plants with increased phosphorous uptake |
| 10/19/2006 | WO2006110506A2 Root-specific phoshate transporter promoters |
| 10/19/2006 | WO2006110413A2 Haemophilus influenzae type b |
| 10/19/2006 | WO2006110240A2 Gene transfer with adenoviruses having modified fiber proteins |
| 10/19/2006 | WO2006110188A2 Genes conferring herbicide resistance |
| 10/19/2006 | WO2006110083A1 A host cell comprising a vector for production of proteins requiring gamma-carboxylation |
| 10/19/2006 | WO2006109855A1 Peptide having food intake stimulating effect and method for screening for the peptide |
| 10/19/2006 | WO2006109781A1 Process for production of glycoprotein composition |
| 10/19/2006 | WO2006109751A1 Method for producing protein by cell-free protein synthesis system |
| 10/19/2006 | WO2006109698A1 Composition comprising genetically engineered erythropoietin |
| 10/19/2006 | WO2006109696A1 Composition comprising genetically engineered follicle-stimulating hormone |
| 10/19/2006 | WO2006109695A1 Composition comprising genetically engineered haptoglobin |
| 10/19/2006 | WO2006109632A1 NOVEL α-KETO ACID TRANSFERASE, GENE FOR THE SAME, AND USE OF THE SAME |
| 10/19/2006 | WO2006109619A1 5-fluorouracil-resistant bacteria and method for production thereof |
| 10/19/2006 | WO2006109592A1 Antibody substituting for function of blood coagulation factor viii |
| 10/19/2006 | WO2006109588A1 Novel microalgae and process for producing hydrocarbon |
| 10/19/2006 | WO2006109578A1 Altered pyrroloquinoline-quinone-dependent glucose dehydrogenase and method of improving substrate specificity of pyrroloquinoline-quinone-dependent glucose dehydrogenase |
| 10/19/2006 | WO2006109535A1 Dna sequence analyzer and method and program for analyzing dna sequence |
| 10/19/2006 | WO2006109533A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method |
| 10/19/2006 | WO2006109479A1 Gene expression cassette and transformant, and process for production of 2-deoxy-scyllo-inosose and process for purification of 2-deoxy-scyllo-inosose using the transformant |
| 10/19/2006 | WO2006109424A1 Dnas encoding protein having function of forming and regulating cellulosic fiber cell wall in tree trunk and promoter dnas of the same |
| 10/19/2006 | WO2006109420A1 Method of examining plant qualities and species |
| 10/19/2006 | WO2006109303A2 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them |
| 10/19/2006 | WO2006109301A2 Molecules and methods of using same for treating mcp-1/ccr2 associated diseases |
| 10/19/2006 | WO2006109192A2 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 10/19/2006 | WO2006109174A2 Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid |
| 10/19/2006 | WO2006109092A1 Conjugate comprising p21 protein for the treatment of cancer |
| 10/19/2006 | WO2006109045A2 Cathepsin s antibody |
| 10/19/2006 | WO2006108830A2 TRANSPLASTOMIC PLANTS EXPRESSING α 1-ANTITRYPSIN |
| 10/19/2006 | WO2006108826A1 Basic protein purification tags from thermophilic bacteria |
| 10/19/2006 | WO2006108718A1 Micro rna |
| 10/19/2006 | WO2006108702A1 High-phosphate starch |
| 10/19/2006 | WO2006108674A2 Elite event a2704-12 and methods and kits for identifying such event in biological samples |
| 10/19/2006 | WO2006108599A2 Ghrelin binding nucleic acids |
| 10/19/2006 | WO2006108590A1 Modified coagulation factor viii with enhanced stability and its derivates |
| 10/19/2006 | WO2006108525A1 Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates |
| 10/19/2006 | WO2006108474A2 Use of a galectin-1-trageted rnai-based approach for the treatment of cancer |
| 10/19/2006 | WO2006108473A1 Method for the determination of cellular transcriptional regulation by micro rnas |
| 10/19/2006 | WO2006108273A1 Identification of a beta-1,3-n-acetylgalactosaminyltransferase (cgte) from campylobacter jejuni lio87 |
| 10/19/2006 | WO2006108226A1 Vaccine delivery system |
| 10/19/2006 | WO2006108201A1 Promoter for the expression of foreign genes in neuronal cells |
| 10/19/2006 | WO2006091824A3 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus |
| 10/19/2006 | WO2006085987A9 Rna interference in respiratory epitheial cells |
| 10/19/2006 | WO2006082398A3 Nucleic acid constructs |
| 10/19/2006 | WO2006078273A3 Methods and compositions for producing recombinant proteins |
| 10/19/2006 | WO2006071691A8 Rnai inhibition of serum amyloid a for treatment of glaucoma |
| 10/19/2006 | WO2006068170A9 Method for improvement of heat stability of glucose dehydrogenase |
| 10/19/2006 | WO2006066078A3 Fcϝriib-specific antibodies and methods of use thereof |
| 10/19/2006 | WO2006065975B1 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 10/19/2006 | WO2006065139A3 Deacylation of lps in gram negative bacteria |
| 10/19/2006 | WO2006065126A3 Terpene hydroxylation |
| 10/19/2006 | WO2006062398A3 Methods for the production and secretion of modified peptides |
| 10/19/2006 | WO2006041910A3 Stem cells derived from uniparental embryos and methods of use thereof |
| 10/19/2006 | WO2006040313A3 Mutant expandases |
| 10/19/2006 | WO2006037081A3 Nanoparticle radiosensitizers |
| 10/19/2006 | WO2006033689A8 Aav mediated gene delivery to cochlear cells |
| 10/19/2006 | WO2006024291A3 Root-specific and xylem parenchyma-specific promoter |
| 10/19/2006 | WO2006023869A3 Adenylate translocator protein gene non-coding regulatory elements for use in plants |
| 10/19/2006 | WO2006023593A3 Malarial animal model having a chimeric human liver |
| 10/19/2006 | WO2006017856A9 Methods for constructing antibiotic resistance free vaccines |
| 10/19/2006 | WO2005097179A3 Stabilised tat antigen and the use thereof for anti-hiv vaccination |
| 10/19/2006 | WO2005094569A8 Ion channel |
| 10/19/2006 | WO2005092924A8 Rab9a, rab11a, and modulators thereof related to infectious disease |
| 10/19/2006 | WO2005089252A3 Methods and compositions for the treatment of obesity |
| 10/19/2006 | WO2005079342A3 Methods for coupling resistance alleles in tomato |
| 10/19/2006 | WO2005070088A3 Chimeric sequences for tissue-specific gene expression in plants |
| 10/19/2006 | WO2005049846A9 Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer |
| 10/19/2006 | WO2005016132A3 Diagnostics for sars virus |
| 10/19/2006 | WO2004084810A3 Novel imidazoline receptor homologs |
| 10/19/2006 | WO2004076638A3 Polynucleotides and polypeptides in plants |